Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients

Applied Clay Science

Volumn 47, Issue 3-4, 2010, Pages 171-181

  Carretero, M Isabel ^a   Pozo, Manuel ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Active ingredients; Cosmetic industry; Minerals; Pharmaceutical industry; Physical and physico chemical properties

Indexed keywords

ACTIVE INGREDIENTS; ANTI-INFLAMMATORIES; BRUCITE; CHEMICAL COMPOSITIONS; COSMETIC INDUSTRY; EPSOMITE; EYE DROPS; GIBBSITES; GOSLARITE; HEAT RETENTION; HIGH REFRACTIVE INDEX; HYDROTALCITES; LOCAL ANESTHETICS; LOW HARDNESS; MELANTERITE; MIRABILITE; PALYGORSKITES; PERICLASE; PHARMACEUTICAL INDUSTRY; PHYSICOCHEMICAL PROPERTY; SMECTITES; SORPTION CAPACITIES; SULPHATES; THERAPEUTIC ACTIVITY;

ANESTHETICS; BORATE MINERALS; CARBONATE MINERALS; CHEMICAL PROPERTIES; DRUG PRODUCTS PLANTS; HYDROXYAPATITE; INDUSTRY; KAOLINITE; MICA; OXIDE MINERALS; REFRACTIVE INDEX; SILICATE MINERALS; SODIUM CHLORIDE; SORPTION; SULFATE MINERALS; SULFUR;

MINERALS;

CHEMICAL COMPOSITION; CLAY MINERAL; HOMEOSTASIS; PHARMACEUTICAL INDUSTRY; PHYSICOCHEMICAL PROPERTY; SOLUBILITY; SORPTION;

EID: 75349091537     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2009.10.016     Document Type: Review

References (40)

1. Bech J. Les Terres Medicinals. Discurs per Reial Academia de Farmàcia de Barcelona (1987), Reial Acadèmia de farmàcia de Barcelona-CIRIT (Generalitat de Catalunya), Barcelona 105 pp
2. Bolger R. Industrial minerals in pharmaceuticals. Industrial Minerals 8 (1995) 52-63
3. Brunton, L.L., Lazo, J.S., Parker, K.L., 2005. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11e. Ed. McGraw-Hill.
4. Carretero M.I. Clay minerals and their beneficial effects upon human health. A review. Applied Clay Science 21 (2002) 155-163
5. Carretero M.I., and Pozo M. Mineralogía Aplicada: Salud y Medio Ambiente (2007), Madrid, Thompson 406 pp
6. Carretero M.I., and Pozo M. Clay and non-clay minerals in the pharmaceutical industry. Part I. Excipients and medical applications. Applied Clay Science 46 (2009) 73-80
7. Carretero M.I., Gomes C., and Tateo F. Clays and human health. In: Bergaya F., Theng B.K.G., and Lagaly G. (Eds). Handbook of Clay Science (2006), Elsevier, Amsterdam 717-741
8. Christidis G.E., Scott P.W., and Dunham A.C. Acid activation and bleaching capacity of bentonites from the islands of Milos and Chios, Aegean, Greece. Applied Clay Science 12 (1997) 329-347
9. Corma A., Mifsud A., and Sanz E. Influence of the chemical composition and textural characteristics of palygorskite on the acid leaching of octahedral cations. Clay Minerals 22 (1987) 225-232
10. Del Amo y Mora M. Programa y Resumen de las Lecciones de Materia Farmacéutica Mineral y Animal (1871), Granada University, Spain
11. Del Hoyo C. Layered double hydroxides and human health: an overview. Applied Clay Science 36 (2007) 103-121
12. Droy-Lefaix M.T., and Tateo F. Clays and clay minerals as drugs. In: Bergaya F., Theng B.K.G., and Lagaly G. (Eds). Handbook of Clay Science (2006), Elsevier, Amsterdam 743-752
13. Galán E., Liso M.J., and Forteza M. Minerales utilizados en la industria farmaceútica. Boletín de la Sociedad Española de Mineralogía 8 (1985) 369-378
14. Galán E., Carretero M.I., and Fernández Caliani J.C. Effects of acid mine drainage on clay minerals suspended in the Tinto River (Río Tinto, Spain). An experimental approach. Clay Minerals 34 (1999) 99-108
15. Gomes C.S.F., and Pereira Silva J.B. Minerals and Human Health. Benefits and Risks. Centro de Investigação«Minerais Industriais e Argilas». Fudação para a Ciência e a Tecnologia do Ministério da Ciência, Tecnologia e Ensino Superior. Aveiro (Portugal) (2006)
16. Gupta A.K., and Nicol K. The use of sulphur in dermatology. Journal of Drugs in Dermatology 3 4 (2004) 427-431
17. In: Guthrie G.D., and Mossman B.T. (Eds). Health effects of mineral dusts. Reviews in Mineralogy vol. 28 (1993), Mineralogical Society of America, Washington, D.C 584 pp
18. Hewitt J.P. Titanium dioxide: a different kind of sunshield. Drug and Cosmetic Industry 151 3 (1992) 26-32
19. 2 and its UV absorption for sunscreen cosmetic applications. Surface and Interface Analysis 38 (2006) 473-477
20. Joekes A.M., Rose G.A., and Sutor J. Multiple renal silica calculi. British Medical Journal 1 (1973) 146-147
21. Jones B.F., and Galán E. Sepiolite and palygorskite. In: Bailey S.W. (Ed). Hydrous Phyllosilicates. Reviews in Mineralogy vol. 19 (1988), Mineralogical Society of America, Washington, D.C 631-674
22. Lefort D., Deloncle R., and Dubois P. Les minéraux en pharmacie. Géosciences 5 (2007) 6-19
23. Leonard A.J., Droy-Lefaix M.T., and Allen A. Pepsin hydrolysis of the adherent mucus barrier and subsequent gastric mucosal damage in the rat: effect of diosmectite and 16, 16 dimethyl prostaglandin E2. Gastroenterologie Clinique et Biologique 8 (1994) 609-616
24. Levison D.A., Crocker P.R., Banim S., and Wallace D.M.A. Silica stones in the urinary bladder. Lancet 27 (1982) 704-705
25. Lin A.N., Reimer R.J., and Carter D.M. Sulphur revisited. Journal of the American Academy of Dermatology 18 3 (1988) 553-558
26. López Galindo A., and Viseras C. Pharmaceutical and cosmetic applications of clays. In: Wypych F., and Satyanarayana K.G. (Eds). Clay Surfaces. Fundamentals and Applications (2004), Elsevier, Amsterdam 267-289
27. Love P. Mineral makeover. Industrial Minerals 9 (2004) 56-57
28. Novak I., and Čičel B. Dissolution of smectites in hydrochloric acid: II. Dissolution rate as a function of crystallochemical composition. Clays and Clay Minerals 26 (1978) 341-344
29. Orchardson R., and Gillam D.G. The efficacy of potassium salts as agents for treating dentin hypersensitivity. Journal of Orofacial Pain 14 1 (2000) 9-19
30. Pla Delfina J.M., and Del Pozo Ojeda A. Manual de Iniciación a la Biofarmacia (1974), Romargraf, S.A., Barcelona 315 pp
31. Sanfilippo A., and English J.C. An overview of medicated shampoos used in dandruff treatment. P&T 31 7 (2006) 396-400
32. Shapiro J., and Maddin S. Medicated shampoos. Clinics in Dermatology 14 (1996) 123-128
33. 27Al MAS-NMR. Clay Minerals 29 (1994) 11-19
34. Veniale F. Clay science: facts and perspectives. Proceedings of the Mediterranean Clay Meeting, Lipari 27-30 September 1992. Mineralogica et Petrographica Acta vol. XXXV-A (1992) 13-44
35. Veniale F. Applicazioni e utilizzazioni medico-sanitarie di materiali argillosi (naturali e modificati). In: Morandi N., and Dondi M. (Eds). Argille e Minerali delle Argille. Guida alla Definizione di Caratteristiche e Proprietà per gli Usi Industriali (1997), Corso di Formazione, Gruppo Ital. AIPEA, Rimini, Italy 205-239
36. Vicente Rodríguez M.A., López González J.D., and Bañares Muñoz M.A. Acid activation of a Spanish sepiolite: physicochemical characterization, free silica content and surface area of products obtained. Clay Minerals 29 (1994) 361-367
37. Vicente Rodríguez M.A., López González J.D., Bañares Muñoz M.A., and Casado Linarejos J. Acid activation of a Spanish sepiolite: II. Consideration of kinetics and physicochemical modifications generated. Clay Minerals 30 (1995) 315-323
38. Viseras C., Aguzzi C., Cerezo P., and Lopez-Galindo A. Uses of clay minerals in semisolid health care and therapeutic products. Applied Clay Science 36 (2007) 37-50
39. Wagner J.C., McConnochie K., Gibbs A.R., and Pooley F.D. Clay minerals and health. In: Parker A., and Rae J.E. (Eds). Environmental Interactions of Clays (1998), Springer-Verlag, Berlin 243-265
40. Wara-aswapati N., Krongnawakul D., Jiraviboon D., Adulyanon S., Karimbux N., and Pitiphat W. The effect of a new toothpaste containing potassium nitrate and triclosan on gingival health, plaque formation and dentine hypersensitivity. Journal of Clinical Periodontology 32 1 (2005) 53-58